ASX Announcement Results of General Meeting Sydney Australia, 2 September 2026 : In accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth), the results of the Recce Pharmaceuticals Limited ( ASX:RCE, FSE:R9Q ), General Meeting held today at...
Recce Pharmaceuticals: Results of General Meeting
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
In the deck
Earlier from Recce Pharmaceuticals
- General Meeting Presentation
- Appendix 4E and FY26 Annual Report
- Appendix 4G
- HREC Approves Comparator Study for Pivotal Phase 3 DFI
- Change of Director's Interest Notices (x4)
Later from Recce Pharmaceuticals
- 2026 Annual General Meeting
- Resolutions under section 249N of the Corporations Act
- Notification of cessation of securities - RCE
- Notice of Annual General Meeting/Proxy Form
- Amendments to Debt Facility with Avenue Capital Group
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals